🇺🇸 FDA
Patent

US 9550002

Phospholipid analogs as diapeutic agents and methods thereof

granted A61KA61K49/0017A61K51/04

Quick answer

US patent 9550002 (Phospholipid analogs as diapeutic agents and methods thereof) held by CELLECTAR BIOSCIENCES, INC. expires Mon Jan 19 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
CELLECTAR BIOSCIENCES, INC.
Grant date
Tue Jan 24 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 19 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
34
CPC classes
A61K, A61K49/0017, A61K51/04, A61K51/0408, A61K51/0489